Exploring better strategies for EGFR antibodies in colon cancer
Author:
Publisher
Elsevier BV
Subject
Oncology
Reference11 articles.
1. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making;Schmoll;Ann Oncol,2012
2. The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus;Adam;Oncologist,2012
3. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer;Douillard;N Eng J Med,2013
4. Stintzing S, Jung A, Rossius L, et al. Analysis of KRAS/NRAS and BRAF mutations in FIRE-3: a randomized phase III study of FOLFIRI plus cetuximab or bevacizumab as first-line treatment for wild-type (WT) KRAS (exon 2) metastatic colorectal cancer (mCRC) patients. European Cancer Congress 2013; Amsterdam, Netherlands; Sept 27–Oct 1, 2013.
5. Intermittent chemotherapy plus either intermittent or continuous cetuximab for first-line treatment of patients with KRAS wild-type advanced colorectal cancer (COIN-B): a randomised phase 2 trial;Wasan;Lancet Oncol,2014
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A five-year follow up study of stage I-IV of rectal cancer with an emphasis on epidermal growth factor over-expression;Polish Journal of Pathology;2021
2. EGFR/PPARδ/HSP90 pathway mediates cancer cell metabolism and chemoresistance;Journal of Cellular Biochemistry;2020-11-08
3. Acetylshikonin Sensitizes Hepatocellular Carcinoma Cells to Apoptosis through ROS-Mediated Caspase Activation;Cells;2019-11-19
4. Ipatasertib sensitizes colon cancer cells to TRAIL-induced apoptosis through ROS-mediated caspase activation;Biochemical and Biophysical Research Communications;2019-11
5. How does EGFR overexpression affect the development and treatment of rectal cancer?;Medical Studies;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3